Retrospective Observational Study of ALK-Inhibitor Therapy Sequencing and Outcomes in Patients with ALK-Positive Non-small Cell Lung Cancer

• Main Authors: David M. Waterhouse (Author), Janet L. Espirito (Author), Marc D. Chioda (Author), Bismark Baidoo (Author), Jack Mardekian (Author), Nicholas J. Robert (Author), Elizabeth T. Masters (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2020-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Data are sparse concerning the sequential use of multiple anaplastic lymphoma kinase (ALK) inhibitors for ALK-positive locally advanced or metastatic non-small cell lung cancer (NSCLC). Objective This study investigated sequencing and outcomes among patients receiving multiple AL...